Last reviewed · How we verify
CAB-ROR2-ADC
At a glance
| Generic name | CAB-ROR2-ADC |
|---|---|
| Also known as | BA3021 |
| Sponsor | BioAtla, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CAB-ROR2-ADC CI brief — competitive landscape report
- CAB-ROR2-ADC updates RSS · CI watch RSS
- BioAtla, Inc. portfolio CI